Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 22330810)

1.

The risks of PPI therapy.

Moayyedi P, Leontiadis GI.

Nat Rev Gastroenterol Hepatol. 2012 Feb 14;9(3):132-9. doi: 10.1038/nrgastro.2011.272. Review.

PMID:
22330810
2.

Recent safety concerns with proton pump inhibitors.

Chen J, Yuan YC, Leontiadis GI, Howden CW.

J Clin Gastroenterol. 2012 Feb;46(2):93-114. doi: 10.1097/MCG.0b013e3182333820. Review.

PMID:
22227731
3.

Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies.

Ngamruengphong S, Leontiadis GI, Radhi S, Dentino A, Nugent K.

Am J Gastroenterol. 2011 Jul;106(7):1209-18; quiz 1219. doi: 10.1038/ajg.2011.113. Epub 2011 Apr 12. Review.

PMID:
21483462
4.

Proton pump inhibitors: potential adverse effects.

Abraham NS.

Curr Opin Gastroenterol. 2012 Nov;28(6):615-20. doi: 10.1097/MOG.0b013e328358d5b9. Review.

PMID:
23010681
5.

Proton pump inhibitor and clopidogrel interaction: fact or fiction?

Laine L, Hennekens C.

Am J Gastroenterol. 2010 Jan;105(1):34-41. doi: 10.1038/ajg.2009.638. Epub 2009 Nov 10. Review.

PMID:
19904241
6.

Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections.

Laria A, Zoli A, Gremese E, Ferraccioli GF.

Reumatismo. 2011 Mar;63(1):5-10. Review.

PMID:
21509344
7.

[Emergent adverse effects of proton pump inhibitors].

Bourne C, Charpiat B, Charhon N, Bertin C, Gouraud A, Mouchoux C, Skalli S, Janoly-Dumenil A.

Presse Med. 2013 Feb;42(2):e53-62. doi: 10.1016/j.lpm.2012.09.016. Epub 2012 Dec 10. Review. French.

PMID:
23237784
8.

Long-term acid inhibition: benefits and harms.

Tepeš B.

Dig Dis. 2011;29(5):476-81. doi: 10.1159/000331519. Epub 2011 Nov 16. Review.

PMID:
22095013
9.

Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis.

Siller-Matula JM, Jilma B, Schrör K, Christ G, Huber K.

J Thromb Haemost. 2010 Dec;8(12):2624-41. doi: 10.1111/j.1538-7836.2010.04049.x. Review.

PMID:
20831618
10.

[Adverse events associated with long-term use of proton pump inhibitors].

Reimer C, Bytzer P.

Ugeskr Laeger. 2012 Sep 24;174(39):2289-93. Danish.

PMID:
23006222
11.

Clopidogrel and proton pump inhibitors: is there a significant drug-drug interaction?

Shmulevich E, Friger M, Gilutz H, Azab AN.

Can J Cardiovasc Nurs. 2011;21(4):27-36. Review.

PMID:
22165503
12.

Fracture risk and bone mineral density reduction associated with proton pump inhibitors.

Lau YT, Ahmed NN.

Pharmacotherapy. 2012 Jan;32(1):67-79. doi: 10.1002/PHAR.1007. Review.

PMID:
22392829
13.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

14.

Systematic review of the risk of enteric infection in patients taking acid suppression.

Leonard J, Marshall JK, Moayyedi P.

Am J Gastroenterol. 2007 Sep;102(9):2047-56; quiz 2057. Epub 2007 May 17. Review.

PMID:
17509031
15.

Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.

Hermos JA, Young MM, Fonda JR, Gagnon DR, Fiore LD, Lawler EV.

Clin Infect Dis. 2012 Jan 1;54(1):33-42. doi: 10.1093/cid/cir767. Epub 2011 Nov 18.

16.

Drug-drug interaction profiles of proton pump inhibitors.

Ogawa R, Echizen H.

Clin Pharmacokinet. 2010 Aug;49(8):509-33. doi: 10.2165/11531320-000000000-00000. Review.

PMID:
20608754
17.

[Clopidogrel--proton pump inhibitors drug interaction: implications to clinical practice].

Fontes-Carvalho R, Albuquerque A.

Rev Port Cardiol. 2010 Oct;29(10):1555-67. Review. Portuguese.

18.

A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.

Hsiao FY, Tsai YW, Huang WF, Wen YW, Chen PF, Chang PY, Kuo KN.

Clin Ther. 2009 Sep;31(9):2038-47. doi: 10.1016/j.clinthera.2009.09.005.

PMID:
19843493
19.

Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitors.

Roux C, Goldstein JL, Zhou X, Klemes A, Lindsay R.

Osteoporos Int. 2012 Jan;23(1):277-84. doi: 10.1007/s00198-011-1574-5. Epub 2011 Mar 2.

PMID:
21365461
20.

[Dilemma between gastroprotection and cardiovascular prevention].

Venerito M, Kandulski A, Malfertheiner P.

Dtsch Med Wochenschr. 2010 Nov;135(44):2193-8. doi: 10.1055/s-0030-1267498. Epub 2010 Oct 26. Review. German.

PMID:
20979006
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk